Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XELOX vs Capecitabine in Elderly Advanced Gastric Cancer
NCT01470742Phase 3Withdrawn
- Sponsor
- Samsung Medical Center
- Start
- Sep 2010
- Primary completion
- Feb 2015
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin in gastric cancer (GC), sponsored by Samsung Medical Center. Planned start Sep 2010; status: withdrawn.
02
Drugs
oxaliplatin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01470742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01470742.